Influenza virus vaccine intranasal - West Pharmaceuticals
Latest Information Update: 24 Oct 2021
Price :
$50 *
At a glance
- Originator West Pharmaceutical Services
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 21 Dec 2004 Discontinued - Phase-I for Influenza virus infections in United Kingdom (Intranasal)
- 21 Dec 2004 Phase-I clinical trials in Influenza virus infections in USA (Intranasal)
- 13 Sep 2004 No development reported - Phase-I for Influenza virus infections in United Kingdom (Intranasal)